• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LEMAITRE VASCULAR, INC. VASCUTAPE RADIOPAQUE TAPE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LEMAITRE VASCULAR, INC. VASCUTAPE RADIOPAQUE TAPE Back to Search Results
Catalog Number 1108-20
Medical Device Problem Code Human-Device Interface Problem (2949)
Health Effect - Clinical Codes Radiation Burn (1755); Pain (1994); Skin Inflammation/ Irritation (4545)
Date of Event 02/15/2024
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
It was reported that the vascutape was not removed from the patient's leg for two weeks after the procedure.The vascutape product is not intended to be placed on the patient for more than 24 hours.The patient underwent an mri while the product was still on the patient.As a result, the markings of the tape were burned onto the patient's leg during the mri and excoriated down toward the ankle causing peeling and redness.The patient required treatment for wound care and antibiotics to prevent infection.It was determined that this issue is due to a user error.The vascutape product is not intended to be left on the patient for more than 24 hours and is not suitable for use in an mri procedure.When the product was left on the patient, it caused a reaction when the patient went through the mri procedure resulting in the event.The lot history record for the device was reviewed, no issues were found during manufacturing or packaging that would cause or contribute to the reported event.We have not received any similar complaints related to this lot number.
 
Event or Problem Description
Tape was not removed from patient's leg for two weeks after procedure.Patient underwent mri with tape inadvertantly on his leg, resulting in pain and redness, as well as burn of the tape markings as an imprint on the patient's leg after tape was finally removed.Patient had angio procedure in ir suite on (b)(6) 2024, followed by lysis case the following day; issue arose when mri conducted 2 weeks later on (b)(6) 2024 with tape still on.Patient finally removed tape from his leg (b)(6) 2024, several days after mri, and observed the redness and markings.Tape measurement markings were burned into patient's leg during mri; excoriated down towards the ankle, peeling and red.Patient is being treated with wound care and antibiotics and was discharted but followed up with by ir suite on (b)(6) 2024.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VASCUTAPE RADIOPAQUE TAPE
Common Device Name
TAPE
Manufacturer (Section D)
LEMAITRE VASCULAR, INC.
63 second ave
burlington MA 01803
Manufacturer (Section G)
LEMAITRE VASCULAR, INC
63 second ave
burlington MA 01803
Manufacturer Contact
peter song
63 second ave
burlington, MA 01803
7814251683
MDR Report Key18907870
Report Number1220948-2024-00063
Device Sequence Number15329768
Product Code KFX
UDI-Device Identifier00840663100385
UDI-Public(01)00840663100385
Combination Product (Y/N)N
Initial Reporter StateCT
Initial Reporter CountryUS
PMA/510(K) Number
K932184
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date (Section B) 03/14/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number1108-20
Device Lot NumberGTF1119
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 03/14/2024
Initial Report FDA Received Date03/14/2024
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured06/23/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-